Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?
27/6 10:53
Up-and-coming telehealth company Hims & Hers Health (NYSE: HIMS) has capitalized on the weight loss drug craze to become one of the market's top performers over the past few years....